Irlene Shen is currently studying MSc Health Economics at the University of York. She received her MSc in Clinical Drug Development at Queen Mary, University of London in 2013. She worked as a clinical pharmacist in the hospital in Taiwan and specialized in Asthma, Diabetes Mellitus and Cardiovascular diseases. She is interested in Health Technology assessment (HTA) of new innovation, Health Economics and Outcome Research, hopefully to bring her previous experience in cancer research, clinical pharmacist and knowledge of clinical drug development to a market access of new innovation. In her spare time, she is also passionate about singing, dancing , travelling and preparing for new career as health economist.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
